A list of the top 15 biopharma M&A mistakes of the last decade has been compiled. The biopharma industry has seen significant activity, including large deals and potential acquisitions, although the specifics of these transactions are unclear. The industry's landscape has shifted over the years, with various companies ranking among the top in terms of revenue at different times.